Document is current

Article History

Accepted: 2 November 2022

First Online: 8 November 2022

Declarations

:

: KFC has received honoraria for participating on Advisory Board meetings of GSK, AstraZeneca, Novartis, Merck, Nocion, Shionogi and Reckitt Benckiser and on the Scientific Advisory Board of the Clean Breathing Institute supported by Haleon. He has also been renumerated for speaking engagements by AZ, Novartis and Merck. He holds research grants from Merck and GSK. SSB has received consultancy fees from Merck, Nerre, Patara, Nocion, Trevi, Roche, Boehringer Ingelheim, Genentech and Axalbion. AHM has received consulting fees from Bayer, Bellus, Merck, NeRRi and Shionogi. Lecture fees from Boehringer Ingelheim, Merck and Chiesi and grant support from Bayer, Bellus, Merck, Nocion, Philips, NeRRi and Shionogi. LPM declares research grants paid to institution by Chiesi, Merck, Bellus Health, Bayer and Shionogi. Personal fees paid for Advisory Board and consultancy by Merck, NeRRe Pharmaceuticals, Menlo, Bellus, Bayer, Genentech, Shionogi, Nocion, Bionorica and Applied Clinical Intelligence; non-financial interest as Co-Chair of ERS NEuroCOUGH Clinical Research Consortium. SBM declares honoraria from Merck, NeRRe Therapeutics, Reckitt Benckiser and Bellus Health and grant support from Merck, Reckitt Benckiser and Bellus Health. TMM has received consulting fees from Boehringer Ingelheim, Roche/Genentech, Astra Zeneca, Bayer, Blade Therapeutics, Bristol Myers Squibb, CSL Behring, Galapagos and Galecto. GlaxoSmithKline, IQVIA, Pfizer, Pliant, Respivant, Sanofi, Theravance, Trevi Therapeutics, Veracyte and Vicore. PVD has received consulting fees from Bayer, Bellus, Chiesi, Merck, Shionogi and Trevi Therapeutics. He is the Editor-in-Chief of <i>LUNG</i>.

Free to read: This content has been made available to all.